Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

15.97
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
8.12
Today|||52-Week Range
22.00
+46.38%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 15.00, with a high estimate of 25.00 and a low estimate of 14.00. The median estimate represents a -6.07% decrease from the last price of 15.97.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.44
Sales
$62.0M
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 45.87%
 
 
 
 
 
 
Growthannually 42.66%
 
 
 
 
 
 

Sales

Growthquarterly 48.15%
 
 
 
 
 
 
Growthannually 118.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.